Letaplimab (Anti-CD47)
Letaplimab (Anti-CD47) is a human immunoglobulin G4 (IgG4) monoclonal antibody targeting leukocyte surface antigen CD47 with potential immunostimulating and antineoplastic activities. MW : 142.88 KD.
| Supplier | Selleck Chemicals |
|---|---|
| Product # | A2824 |
| Sku # | A2824-1mg*5 |
| Pricing | 1mg*5, $970.00 |